These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11120014)

  • 1. Impact of hepatitis C virus infection in renal allograft recipients.
    Yacheng Y; Zhilian M; Yeuhua Z
    Transplant Proc; 2000 Nov; 32(7):1949. PubMed ID: 11120014
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced severity of acute rejection in hepatitis C virus positive renal allograft recipients: are milder immunosuppressive regimens advisable?
    Pascual J; Crespo M; Mateos ML; Marcén R; Orofino L; Burgos FJ; Liaño F; Ortuño J
    Transplant Proc; 1998 Jun; 30(4):1329-30. PubMed ID: 9636540
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term evolution of anti-HCV-positive renal transplant recipients.
    Aroldi A; Lampertico P; Elli A; Lunghi G; Tarantino A; Montagnino G; Colombo M; Ponticelli C
    Transplant Proc; 1998 Aug; 30(5):2076-8. PubMed ID: 9723397
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of chronic liver disease on clinical outcome in renal allograft recipients.
    Durlik M; Gaciong Z; Soluch L; Rowińska D; Rancewicz Z; Kozłowska-Boszko B; Lewandowski Z; Rowiński W; Szmidt J; Lao M
    Transplant Proc; 1997; 29(1-2):787-90. PubMed ID: 9123526
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C virus infection and renal transplantation.
    Morales JM
    Transplant Proc; 1999 Sep; 31(6):2221-4. PubMed ID: 10500553
    [No Abstract]   [Full Text] [Related]  

  • 6. Kidney transplantation from a donor who is HCV antibody positive and HCV-RNA negative.
    Tokumoto T; Tanabe K; Simizu T; Shimmura H; Iizuka J; Ishikawa N; Oshima T; Yagisawa T; Goya N; Nakazawa H; Toma H
    Transplant Proc; 2000 Nov; 32(7):1597-9. PubMed ID: 11119853
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of anti HCV (+) on renal transplantation.
    Han DJ; Jung JH; Jang HJ; Kim SK; Kim SC
    Transplant Proc; 2000 Nov; 32(7):1939. PubMed ID: 11120010
    [No Abstract]   [Full Text] [Related]  

  • 8. HCV antibody positivity significantly affects renal allograft survival.
    Ozdemir FN; Micozkadioglu H; Sezer S; Arat Z; Gürsoy M; Boyacioglu S; Haberal M
    Transplant Proc; 2003 Nov; 35(7):2701-2. PubMed ID: 14612081
    [No Abstract]   [Full Text] [Related]  

  • 9. Graft dysfunction and polyomavirus infection in renal allograft recipients.
    Maiza H; Fontaniere B; Dijoud F; Pouteil-Noble C
    Transplant Proc; 2002 May; 34(3):809-11. PubMed ID: 12034191
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between hepatitis C virus infection and human leucocyte antigens in renal transplant patients.
    Tuncer M; Sarikaya M; Yegin O; Süleymanlar G; Ersoy F; Yakupoglu G
    Transplant Proc; 1999 Dec; 31(8):3343-5. PubMed ID: 10616500
    [No Abstract]   [Full Text] [Related]  

  • 11. The long-term outcomes of hepatitis C virus core antigen-positive Japanese renal allograft recipients.
    Okino K; Okushi Y; Mukai K; Matsui Y; Hayashi N; Fujimoto K; Adachi H; Yamaya H; Yokoyama H
    Clin Exp Nephrol; 2017 Dec; 21(6):1113-1123. PubMed ID: 28357506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term impact of hepatitis B and C virus infection in kidney transplant recipient's survival.
    Correa JR; Rocha F; Peres AA; Gonçalves LF; Manfro RC
    Transplant Proc; 2003 May; 35(3):1076-7. PubMed ID: 12947864
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C virus infection in kidney transplant recipients.
    Valeri M; Pisani F; De Paolis P; Piazza A; Torlone N; Utzeri G; Elli M; Tisone G; Adorno D; Casciani CU
    Transplant Proc; 1993 Jun; 25(3):2284-5. PubMed ID: 7685948
    [No Abstract]   [Full Text] [Related]  

  • 14. The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients.
    Cosio FG; Sedmak DD; Henry ML; Al Haddad C; Falkenhain ME; Elkhammas EA; Davies EA; Bumgardner GL; Ferguson RM
    Transplantation; 1996 Oct; 62(8):1054-9. PubMed ID: 8900300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of hepatitis C virus infection in adult renal graft recipients.
    Aroldi A; Lampertico P; Montagnino G; Lunghi G; Passerini P; Villa M; Campise M; Cesana BM; Ponticelli C
    Transplant Proc; 2005 Mar; 37(2):940-1. PubMed ID: 15848581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early graft dysfunction developed within one week after renal allograft.
    Kim SC; Jang HJ; Kim SK; Kim TH; Yoo ES; Jung JG; Han DJ
    Transplant Proc; 2000 Nov; 32(7):1886-7. PubMed ID: 11119985
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement.
    Bouthot BA; Murthy BV; Schmid CH; Levey AS; Pereira BJ
    Transplantation; 1997 Mar; 63(6):849-53. PubMed ID: 9089225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of anti-HCV(+) renal allograft recipients.
    Lee SW; Kang SW; Choi KH; Han KH; Lee HY; Han DS; Kim YS; Park K
    Transplant Proc; 1996 Jun; 28(3):1501-2. PubMed ID: 8658759
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis C in kidney transplant patients.
    Oka T; Yasumura T
    Transplant Proc; 1996 Jun; 28(3):1163-7. PubMed ID: 8658612
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomised trial of simulect versus placebo for control of acute rejection in renal allograft recipients.
    Bingyi S; Yeyong Q; Ming C; Chunbai M; Wenqiang Z
    Transplant Proc; 2003 Feb; 35(1):192-4. PubMed ID: 12591362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.